GlassScriptPhysician profile
Abner Eric Vazquez Pabon
NPI 1932652740
$760.92
in general payments reported to CMS, 2019-2025
10 companies · $53.84 in 2025
The $53.84 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24.88 · 2021: $33.57 · 2022: $129 · 2023: $395 · 2024: $125 · 2025: $53.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ns Pharma, INC. | $249.99 | 2023-2024 | Viltepso |
| Genentech USA, INC. | $150.00 | 2023 | Evrysdi |
| Genzyme Corporation | $114.90 | 2022 | |
| Biogen, INC. | $100.00 | 2023 | Spinraza |
| Abbvie INC. | $53.84 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.88 | 2020 | |
| Acorda Therapeutics, INC | $19.74 | 2023 | Inbrija |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.57 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $14.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abner Vazquez Pabon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.